Crohn's Naltrexone Pilot Shows Effect
A Penn State College of Medicine pilot study suggests that a drug used to ease symptoms of alcohol and drug addiction (naltrexone) may also bring relief to people with Crohn's disease.
In the study, people with diagnosed Crohn's disease were treated with a low dose of naltrexone (LDN), an FDA-approved drug used to ease symptoms of withdrawal from substance abuse, and monitored for improvement of symptoms for 12 weeks. Quality of life surveys were given every four weeks for 16 weeks.
The results showed that 89 percent of participants showed an improvement with therapy, while 67 percent achieved remission of symptoms. The only side effect to treatment was sleep disturbance in some patients.
LDN is used by some people with MS with many anecdotal reports of benefit. We'd love to see an MS trial with LDN take place.


LDN's rose coloured glasses.
I saw Dr. Smith's presentation....